Key Considerations Before Investing in CRH Stock

Large-cap Industrials company CRH has moved -3.4% so far today on a volume of 5,542,800, compared to its average of 5,254,030. In contrast, the S&P 500 index moved 0.0%.

CRH trades -23.64% away from its average analyst target price of $100.25 per share. The 18 analysts following the stock have set target prices ranging from $87.0 to $113.0, and on average have given CRH a rating of buy.

Anyone interested in buying CRH should be aware of the facts below:

  • CRH's current price is 44.2% above its Graham number of $53.09, which implies that at its current valuation it does not offer a margin of safety

  • CRH has moved 44.8% over the last year, and the S&P 500 logged a change of 23.8%

  • Based on its trailing earnings per share of 4.54, CRH has a trailing 12 month Price to Earnings (P/E) ratio of 16.9 while the S&P 500 average is 27.65

  • CRH has a forward P/E ratio of 12.9 based on its forward 12 month price to earnings (EPS) of $5.93 per share

  • The company has a price to earnings growth (PEG) ratio of 1.43 — a number near or below 1 signifying that CRH is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 2.63 compared to its sector average of 3.23

  • CRH plc, together with its subsidiaries, provides building materials solutions in Ireland and internationally.

  • Based in Dublin, the company has 78,500 full time employees and a market cap of $52.4 Billion. CRH currently returns an annual dividend yield of 2.1%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.